<DOC>
	<DOCNO>NCT00798447</DOCNO>
	<brief_summary>Evaluation impact peri- post-operative parenteral nutrition enrich n-3 PUFA post-operative inflammatory process .</brief_summary>
	<brief_title>Efficacy Safety PN Regimen Containing n-3 Fatty Acid Patients Considered After GI Surgery</brief_title>
	<detailed_description />
	<criteria>Patients consider major surgery gastric colorectal cancer expect requirement post operative PN TPN least 7 day possibility PN/TPN provision 1 day prior surgery Age &gt; 18 year old &lt; 80 year old Hemodynamically stable Written Informed consent Participation clinical study investigational drug investigational medical device within one month prior start study Patients sepsis , severe sepsis septic shock Known suspect drug abuse Intrahepatic cholestasis General contraindication infusion therapy acute pulmonary edema , hyperhydration decompensated cardiac insufficiency Pregnancy ( positive urine ) lactation Autoimmune disease e.g . HIV Known hypersensitivity egg , soy , fish protein ingredient investigational product Hemodynamic failure origin ( hemorrhagic shock , myocardial infarction , cardiac failure ) Alterations coagulation ( thrombocytes &lt; 150000 /mm3 ) , PT &lt; 50 % , PTT &gt; 40 sec Ketoacidosis cause Diabetes mellitus within 7 day prior onset study Renal insufficiency serum creatinine &gt; 1.4 mg/dL ( &gt; 124 µmol/L ) Patients severe liver dysfunction bilirubin &gt; 2.5 mg/dL ( &gt; 43 µmol/L ) Lipid disorder , particular fast serum triglyceride &gt; 250 mg/dL ( &gt; 2.85 mmol/L ) ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>post OP</keyword>
</DOC>